Adamas Pharmaceuticals' Series B Round

Adamas Pharmaceuticals raised a round of funding on May 19, 2005.

Adamas, formerly NeuroMolecular Pharmaceuticals, is a pharmaceutical company focused on developing small molecule, advantaged therapeutics to treat neurological and infectious diseases, including infl…

Articles about Adamas Pharmaceuticals' Series B Round: